here is part of the new announcement today:
PRIMA BIOMED ANNOUNCES LICENSING AGREEMENT FOR CRIPTO-1
CANCER IMMUNOTHERAPY TREATMENT
Australian health care company Prima BioMed Ltd (ASX: PRR) (Prima) is pleased to announce that its subsidiary company, Oncomab Pty Ltd (Oncomab), has entered into
a licensing agreement for the development of a Cripto-1 cancer monoclonal antibody (mAB) with leading Dutch pharmaceutical development company Bioceros.
The licensing agreement paves the way for the further development of Oncomabs technology to create a Cripto-1 mAB as an immunotherapy treatment for cancers.
Bioceros is one of Europes premier providers of services related to the pre-clinical development of mABs and generation of GMP-ready protein producing cell lines
(CHO and PER.C6). The Company currently provides services to multiple customersfrom the biotech and food industries
http://www.asx.com.au/asx/statistics/announcements.do?by=asxCode&asxCode=prr&timeframe=D&period=W
parternering agreement prima's cripto-1
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.5¢ | $251.5K | 806.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 121215 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 2864 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |